These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 213506)

  • 1. Comparison of myeloperoxidase activity in leukocytes from normal subjects and patients with chronic granulomatous disease.
    Pegram PS; DeChatelet LR; McCall CE
    J Infect Dis; 1978 Nov; 138(5):699-702. PubMed ID: 213506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of myeloperoxidase and bacterial metabolism in chemiluminescence of granulocytes from patients with chronic granulomatous disease.
    Allen RC; Mills EL; McNitt TR; Quie PG
    J Infect Dis; 1981 Oct; 144(4):344-8. PubMed ID: 6270214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of myeloperoxidase in the microbicidal activity of polymorphonuclear leukocytes.
    Klebanoff SJ; Rosen H
    Ciba Found Symp; 1978 Jun 6-8; (65):263-84. PubMed ID: 225142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloperoxidase.
    Klebanoff SJ
    Proc Assoc Am Physicians; 1999; 111(5):383-9. PubMed ID: 10519157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic granulomatous disease (CGD) and complete myeloperoxidase deficiency both yield strongly reduced dihydrorhodamine 123 test signals but can be easily discerned in routine testing for CGD.
    Mauch L; Lun A; O'Gorman MR; Harris JS; Schulze I; Zychlinsky A; Fuchs T; Oelschlägel U; Brenner S; Kutter D; Rösen-Wolff A; Roesler J
    Clin Chem; 2007 May; 53(5):890-6. PubMed ID: 17384005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of lysosomal enzymes by the respiratory burst of polymorphonuclear leukocytes. Possible involvement of myeloperoxidase-H2O2-halide system.
    Kobayashi M; Tanaka T; Usui T
    J Lab Clin Med; 1982 Dec; 100(6):896-907. PubMed ID: 6292313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of phagocytosis in chronic granulomatous disease.
    Gaither TA; Medley SR; Gallin JI; Frank MM
    Inflammation; 1987 Jun; 11(2):211-27. PubMed ID: 3034783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NADPH oxidase deficiency in X-linked chronic granulomatous disease.
    Hohn DC; Lehrer RI
    J Clin Invest; 1975 Apr; 55(4):707-13. PubMed ID: 235560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of nitric oxide consumption pathways by normal, chronic granulomatous disease and myeloperoxidase-deficient human neutrophils.
    Clark SR; Coffey MJ; Maclean RM; Collins PW; Lewis MJ; Cross AR; O'Donnell VB
    J Immunol; 2002 Nov; 169(10):5889-96. PubMed ID: 12421972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic disorders of leukocyte function: what they tell us about normal antimicrobial mechanisms of human phagocytic cells.
    Root RK; Beeson PB
    Klin Wochenschr; 1982 Jul; 60(14):731-4. PubMed ID: 6289003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased phagocytic activity of polymorphonuclear leukocytes of chronic granulomatous disease as determined with flow cytometric assay.
    Hasui M; Hirabayashi Y; Hattori K; Kobayashi Y
    J Lab Clin Med; 1991 Apr; 117(4):291-8. PubMed ID: 1849170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency of NADPH oxidase activity in chronic granulomatous disease.
    McPhail LC; DeChatelet LR; Shirley PS; Wilfert C; Johnston RB; McCall CE
    J Pediatr; 1977 Feb; 90(2):213-7. PubMed ID: 12254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degranulation of leukocytes in chronic granulomatous disease.
    Baehner RL; Karnovsky MJ; Karnovsky ML
    J Clin Invest; 1969 Jan; 48(1):187-92. PubMed ID: 5765020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viricidal effect of stimulated human mononuclear phagocytes on human immunodeficiency virus type 1.
    Chase MJ; Klebanoff SJ
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5582-5. PubMed ID: 1319066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative inactivation of myeloperoxidase released from human neutrophils.
    Edwards SW; Nurcombe HL; Hart CA
    Biochem J; 1987 Aug; 245(3):925-8. PubMed ID: 2822034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethylene formation by polymorphonuclear leukocytes. Role of myeloperoxidase.
    Klebanoff SJ; Rosen H
    J Exp Med; 1978 Aug; 148(2):490-506. PubMed ID: 212502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection.
    Lehrer RI; Cline MJ
    J Clin Invest; 1969 Aug; 48(8):1478-88. PubMed ID: 5796360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogen peroxide production in chronic granulomatous disease. A cytochemical study of reduced pyridine nucleotide oxidases.
    Briggs RT; Karnovsky ML; Karnovsky MJ
    J Clin Invest; 1977 Jun; 59(6):1088-98. PubMed ID: 193872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal leukocyte glutathione peroxidase activity in patients with chronic granulomatous disease.
    DeChatelet LR; Shirley PS; McPhail LC
    J Pediatr; 1976 Oct; 89(4):598-600. PubMed ID: 957003
    [No Abstract]   [Full Text] [Related]  

  • 20. Spectrophotometric studies on NAD(P)H oxidase of leukocytes. 1. The relationship between granule-NAD(P)H oxidase and myeloperoxidase.
    Kakinuma K; Chance B
    Biochim Biophys Acta; 1977 Jan; 480(1):96-103. PubMed ID: 188481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.